Novavax Reports Second Quarter 2020 Financial and Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
Novavax (NVAX) Tops Q2 EPS by 12c, Revenues Miss
August 10, 2020 4:33 PM EDTNovavax (NASDAQ: NVAX) reported Q2 EPS of ($0.30), $0.12 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $35.54 million versus the consensus estimate of $39.58 million.
Novavax unprecedented development activities for NVX-CoV2373 and progress continued through the second quarter, said Stanley C. Erck,... More
